SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Sunglass Hut RAYS- Will it ever breakout?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steven Angelil who wrote (652)10/7/1997 3:27:00 PM
From: Steven Messina,L.M.T.   of 971
 
***Off Topic***

Steve,

Unlike Cymer though, MTZ will provide you with a nice smooth ride upward, with minor dips here and there....a real quality LONG TERM GROWTH company (if you so choose to hold her long term). I margined another 200shs @ 40 7/8....currently around 41 3/8. Remember, Mastec is selling her stakes in certain holdings....gee, maybe she needs some money to buy something. $20,000,000 a couple weeks ago and now another $65,000,000 sale. That's a lot of money to just keep in the bank. Look for acquisition news in the very near future.

Still LONG CYMI at 31 1/8, I think.

RAYS performing well, considering I have no idea why she's above $8/sh.......glad I got out short term. I need to know what the deal is before I venture back in.

MTZ.....what else can I say?

DY...... ditto.

Notice that DY and MTZ have things in common...wink wink.

take care,

steve

P.S. Read this real quick:

Reuters Story - October 02, 1997 14:07

%TEL %US %ES MTZ V%REUTER P%RTR

Jump to first matched term
By Patricia Zengerle
MIAMI, Oct 2 (Reuter) - MasTec Inc shares were off Thursday
on concern that labor unrest in Spain might cut into revenue
and fears about the health of its chairman, but the company's
chief financial officer downplayed concerns about both issues.
"There's some concern about the health of Jorge Mas Canosa,
the founder and chairman of the firm. There's a feeling that
he's been instrumental in growing the firm and getting a lot of
the foreign acquisitions that the company has made," said
Joseph Gladue, an analyst at Chapman Co. in Baltimore.
However, Gladue and other analysts said the company's day
to day operations are handled by Mas Canosa's son, Jorge Mas
Jr., the president and chief executive officer, so the health
of Mas Canosa would have little effect on business. MasTec
Chief Financial Officer Edwin Johnson also said the chairman's
health should not be considered a factor.
"The health of the chairman, although he's getting much
better, really doesn't affect the business, the day to day
operations of the company. His son is the driving force behind
the business," Johnson told Reuters in an interview.
"He has not been involved with our more recent deals at all.
Our Brazilian partners I don't believe have even met him,"
Johnson said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext